Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

ShareHepatitis B remains one of the most pressing yet overlooked public health challenges worldwide. Affecting over 296 million people, this viral infection of the liver has long been labeled a ...

New data reveals deaths in Australia linked to chronic hepatitis B have increased following years of decline, with experts ...

Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil fumarate (TDF) is currently the most widely used antiviral agent for CHB ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / In 2019, Somchai, a Thai native, was 21 years old and faced a double ...

More Australians die from hepatitis B-related illness each year. Now experts are pushing for universal screening for all adults.

Hepatitis Australia is calling for a nationwide rollout of universal offer of hepatitis B testing for people aged over 25, ...